Tayu Huaxia Biotech Medical Group Co., Ltd. is an innovative pharmaceutical company dedicated to the research and development of first-in-class immunotherapy drugs. It was founded in 2016 by world-renowned immunologist and oncologist Dr. Chen Lieping and Royal Seal Group. Our research is being conducted simultaneously in laboratories in the U.S and China to develop immuno-stimulation and coinhibition drugs, bispecific antibodies and biomarkers among others. 大有华夏生物医药集团有限公司，是致力于免疫治疗前沿药物研发的生物科技创新企业，由世界著名免疫学家、肿瘤学家陈列平博士与龙玺科技集团于2016年联合创建，依托陈列平博士美国、中国实验室的药物发现成果开展免疫共刺激/共抑制机理药物、双特异性抗体、生物标志物检测试剂等产品的开发、生产。